13F-HR filed by CAXTON CORP
CAXTON CORP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 16 holding rows worth $74,436,000.
- Accession
- 0000919574-22-004865
- Filer
- CIK 1388551
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 16 entries on the cover page, a total value of $74,436,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $74,436,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| United States Oil Fund LP | 91232N207 | COM | 353,500 | $28,404,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| SAVARA INC | 805111101 | COM | 6,896,551 | $10,483,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 6,039,028 | $9,300,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SPDR GOLD TR | 78463V107 | GOLD SHS | 40,820 | $6,877,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SPY | 78462F103 | SHS | 15,947 | $6,016,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,403,157 | $4,532,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SCYNEXIS INC | 811292200 | COM NEW | 1,723,947 | $3,207,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 2,052,991 | $1,872,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 101,719 | $1,839,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| VECTIVBIO HLDG AG | H9060V101 | COM | 194,577 | $1,051,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 116,884 | $736,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 68,293 | $96,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| BRIDGETOWN HOLDINGS LTD | G1355U121 | *W EXP 09/30/202 | 39,773 | $10,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| LUX HEALTH TECH ACQUISITION | 55068A118 | *W EXP 11/30/202 | 66,666 | $9,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| FRAZIER LIFESCIENCES ACQU CO | G3710A113 | WTS | 21,333 | $2,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| PRIMAVERA CAPITAL ACQUIST CO | G7255E117 | WTS | 12,000 | $2,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-22-004865 | this filing | 2022-08-15 | acceptance time not in the bulk data set |